Top Income Stocks for February 7th Best Income Stocks to Buy for February 7th

Avatar photo

Here’s a rundown of three stocks with buy rank and robust income characteristics, ripe for investors to consider today, February 7.

The Clorox Company – Positioning for Growth

The Clorox Company (CLX) – a stalwart in the realm of consumer and professional products – is on an upward trajectory, with its Zacks Consensus Estimate for current year earnings skyrocketing by 14.9% over the last 60 days.

The Clorox Company Price and Consensus

This Zacks Rank #1 company offers a tempting dividend yield of 3.1%, trumping the industry average of 2.4%.

The Clorox Company Dividend Yield (TTM)

Kemper Corporation – Riding the Wave of Growth

Kemper Corporation (KMPR), an insurance holding company, has been basking in glory as the Zacks Consensus Estimate for its next year earnings soared by 14.9% over the last 60 days.

Kemper Corporation Price and Consensus

This Zacks Rank #1 company boasts a dividend yield of 2.2%, outshining the industry average of 2.1%.

Kemper Corporation Dividend Yield (TTM)

Lancaster Colony Corporation – Nurturing Growth

Lancaster Colony Corporation (LANC), a distinguished food products company, has seen its Zacks Consensus Estimate for next year earnings ascend by 4.4% over the last 60 days.

Lancaster Colony Corporation Price and Consensus

This Zacks Rank #1 company presents a dividend yield of 1.8%, surpassing the industry average of 0.0%.

Lancaster Colony Corporation Dividend Yield (TTM)

Witness the full list of top ranked stocks here.

Explore more top income stocks with some of our premium screens.

Zacks Names “Single Best Pick to Double”

Amidst a myriad of stocks, 5 Zacks experts have each pinned down their favorite, projecting the potential for a whopping +100% or more within months. From this elite segment, Director of Research Sheraz Mian tags one as the most promising.

This stock is hailed for a “watershed medical breakthrough”, and is forging ahead with a bustling pipeline of other projects that could revolutionize the landscape for patients grappling with liver, lung, and blood-related maladies. Seize this opportune investment as it springs back from its bear market lows.

It could rival or surpass other recent Stocks Set to Double feats such as the Boston Beer Company, which soared by +143.0% in a little over 9 months, and NVIDIA, which exploded by +175.9% in just one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Clorox Company (CLX) : Free Stock Analysis Report

Kemper Corporation (KMPR) : Free Stock Analysis Report

Lancaster Colony Corporation (LANC) : Free Stock Analysis Report

Read this article on Zacks.com

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The free Daily Market Overview 250k traders and investors are reading

Read Now